This study aims to: (1) Further characterize CCR4 expression patterns in microglia post‐ICH; (2) Delineate the downstream ERK/AP1/SRA signaling cascade; (3) Evaluate CCL17/CCR4 signaling effects on microglial phenotype and hematoma resolution; (4) Assess the therapeutic potential of targeting this axis in experimental ICH. This evidence concerns the gene CCR4 and hematoma.